"Designing Growth Strategies is in our DNA"

Swine Vaccines Market Size, Share & Industry Analysis, By Technology (Modified-Live Attenuated Vaccines, Inactivated/Killed Vaccines, Bacterins & Toxoid-Based Vaccines, and Recombinant Subunit Vaccines), By Disease Indication (Porcine Reproductive & Respiratory Syndrome, Porcine Circovirus Diseases, Mycoplasma Pneumonia, and Swine Influenza), By Route of Administration (Intramuscular, Intradermal, Oral, and Subcutaneous), By Distribution Channel (Direct Sales to Integrated Producers, Veterinary Distributors & Wholesalers, and Veterinarian-Led Channels), and Regional Forecast, 2026-2034

Last Updated: October 19, 2026 | Format: PDF | Report ID: FBI118648

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Overview: Swine Population, By Key Countries, 2025
    2. Overview: Disease Incidence/Outbreaks of Swine Diseases, By Key Countries, 2025
    3. Overview: Vaccine Technology, Pipeline, and Emerging Vaccination Platforms
    4. Regulatory Scenario for Swine Vaccines, By Key Countries/Regions
    5. New Product Launches, By Key Players
    6. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    7. PESTEL Analysis
    8. Porter’s Five Force Model
  5. Global Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Southeast Asia
      5. Australia
      6. Rest of Asia Pacific
  9. Latin America Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology 
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication   
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration       
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel              
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Boehringer Ingelheim International GmbH
      2. Zoetis Inc.
      3. Merck & Co., Inc.
      4. Ceva Santé Animale
      5. HIPRA, S.A.
      6. Jinyu Bio-Technology Co., Ltd.
      7. Elanco Animal Health Incorporated
      8. China Animal Husbandry Industry Co., Ltd.
      9. Pulike Biological Engineering, Inc.
      10. Tianjin Ringpu Bio-Technology Co., Ltd.
      11. Vaxxinova International B.V.
      12. Phibro Animal Health Corporation
      13. Qilu Animal Health Products Co., Ltd.
      14. Biogénesis Bagó S.A.
      15. Bioveta, a.s.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Overview: Swine Population, By Key Countries, 2025
    2. Overview: Disease Incidence/Outbreaks of Swine Diseases, By Key Countries, 2025
    3. Overview: Vaccine Technology, Pipeline, and Emerging Vaccination Platforms
    4. Regulatory Scenario for Swine Vaccines, By Key Countries/Regions
    5. New Product Launches, By Key Players
    6. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    7. PESTEL Analysis
    8. Porter’s Five Force Model
  5. Global Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Southeast Asia
      5. Australia
      6. Rest of Asia Pacific
  9. Latin America Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology              
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication                
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration    
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel           
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Swine Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Technology 
      1. Modified-Live Attenuated Vaccines
      2. Inactivated/Killed Vaccines
      3. Bacterins and Toxoid-Based Vaccines
      4. Recombinant Subunit and Virus-Like Particle Vaccines
      5. Viral-Vector and Chimeric Vaccines
      6. Nucleic-Acid and Replicon Vaccines
      7. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication   
      1. Porcine Reproductive and Respiratory Syndrome
      2. Porcine Circovirus-Associated Diseases
      3. Mycoplasma-Associated Enzootic Pneumonia
      4. Swine Influenza
      5. Enteric Diseases
      6. Reproductive Diseases
      7. Systemic and Bacterial Diseases
      8. Transboundary and Notifiable Diseases
      9. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration       
      1. Intramuscular
      2. Intradermal
      3. Oral
      4. Subcutaneous
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel              
      1. Direct Sales to Integrated Swine Producers
      2. Veterinary Distributors and Wholesalers
      3. Veterinarian-Led and Animal-Health Service Channels
      4. Agro-Veterinary Retailers and Cooperatives
      5. Government and Public Procurement
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Boehringer Ingelheim International GmbH
      2. Zoetis Inc.
      3. Merck & Co., Inc.
      4. Ceva Santé Animale
      5. HIPRA, S.A.
      6. Jinyu Bio-Technology Co., Ltd.
      7. Elanco Animal Health Incorporated
      8. China Animal Husbandry Industry Co., Ltd.
      9. Pulike Biological Engineering, Inc.
      10. Tianjin Ringpu Bio-Technology Co., Ltd.
      11. Vaxxinova International B.V.
      12. Phibro Animal Health Corporation
      13. Qilu Animal Health Products Co., Ltd.
      14. Biogénesis Bagó S.A.
      15. Bioveta, a.s.
Read Less

Figure 1: Global Swine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Swine Vaccines Market Value Share (%), by Technology, 2025 & 2034

Figure 3: Global Swine Vaccines Market Value Share (%), by Disease Indication, 2025 & 2034

Figure 4: Global Swine Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 5: Global Swine Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 6: Global Swine Vaccines Market Value Share (%), by Region, 2025 & 2034

Figure 7: North America Swine Vaccines Market Value (USD billion), by Technology, 2025 & 2034

Figure 8: North America Swine Vaccines Market Value Share (%), by Technology, 2025

Figure 9: North America Swine Vaccines Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 10 North America Swine Vaccines Market Value Share (%), by Disease Indication, 2025

Figure 11: North America Swine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 12: North America Swine Vaccines Market Value Share (%), by Route of Administration, 2025

Figure 13: North America Swine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: North America Swine Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 15: North America Swine Vaccines Market Value (USD billion), by Country, 2025 & 2034

Figure 16: North America Swine Vaccines Market Value Share (%), by Country, 2025

Figure 17: Europe Swine Vaccines Market Value (USD billion), by Technology, 2025 & 2034

Figure 18: Europe Swine Vaccines Market Value Share (%), by Technology, 2025

Figure 19: Europe Swine Vaccines Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 20: Europe Swine Vaccines Market Value Share (%), by Disease Indication, 2025

Figure 21: Europe Swine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 22: Europe Swine Vaccines Market Value Share (%), by Route of Administration, 2025

Figure 23: Europe Swine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 24: Europe Swine Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 25: Europe Swine Vaccines Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 26: Europe Swine Vaccines Market Value Share (%), by Country/ Sub-region, 2025

Figure 27: Asia Pacific Swine Vaccines Market Value (USD billion), by Technology, 2025 & 2034

Figure 28: Asia Pacific Swine Vaccines Market Value Share (%), by Technology, 2025

Figure 29: Asia Pacific Swine Vaccines Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 30: Asia Pacific Swine Vaccines Market Value Share (%), by Disease Indication, 2025

Figure 31: Asia Pacific Swine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 32: Asia Pacific Swine Vaccines Market Value Share (%), by Route of Administration, 2025

Figure 33: Asia Pacific Swine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 34: Asia Pacific Swine Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 35: Asia Pacific Swine Vaccines Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Swine Vaccines Market Value Share (%), by Country/ Sub-region, 2025

Figure 37: Latin America Swine Vaccines Market Value (USD billion), by Technology, 2025 & 2034

Figure 38: Latin America Swine Vaccines Market Value Share (%), by Technology, 2025

Figure 39: Latin America Swine Vaccines Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 40: Latin America Swine Vaccines Market Value Share (%), by Disease Indication, 2025

Figure 41: Latin America Swine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 42: Latin America Swine Vaccines Market Value Share (%), by Route of Administration, 2025

Figure 43: Latin America Swine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 44: Latin America Swine Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 45: Latin America Swine Vaccines Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Swine Vaccines Market Value Share (%), by Country/ Sub-region, 2025

Figure 47: Middle East & Africa Swine Vaccines Market Value (USD billion), by Technology, 2025 & 2034

Figure 48: Middle East & Africa Swine Vaccines Market Value Share (%), by Technology, 2025

Figure 49: Middle East & Africa Swine Vaccines Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 50: Middle East & Africa Swine Vaccines Market Value Share (%), by Disease Indication, 2025

Figure 51: Middle East & Africa Swine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 52: Middle East & Africa Swine Vaccines Market Value Share (%), by Route of Administration, 2025

Figure 53: Middle East & Africa Swine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 54: Middle East & Africa Swine Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 55: Middle East & Africa Swine Vaccines Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Swine Vaccines Market Value Share (%), by Country/ Sub-region, 2025

Figure 57: Global Swine Vaccines Market Share (%), by Company, 2025

Table 1: Global Swine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 2: Global Swine Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 3: Global Swine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 4: Global Swine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 5: Global Swine Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 6: North America Swine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 7: North America Swine Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 8: North America Swine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 9: North America Swine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 10: North America Swine Vaccines Market Revenue (USD billion) Forecast, by Country, 2021-2034

Table 11: Europe Swine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 12: Europe Swine Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 13: Europe Swine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 14: Europe Swine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 15: Europe Swine Vaccines Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 16: Asia Pacific Swine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 17: Asia Pacific Swine Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 18: Asia Pacific Swine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 19: Asia Pacific Swine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 20: Asia Pacific Swine Vaccines Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 21: Latin America Swine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 22: Latin America Swine Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 23: Latin America Swine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 24: Latin America Swine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 25: Latin America Swine Vaccines Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 26: Middle East & Africa Swine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 27: Middle East & Africa Swine Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 28: Middle East & Africa Swine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 29: Middle East & Africa Swine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 30: Middle East & Africa Swine Vaccines Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Swine Vaccines Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports